We are live on ! Find out more
IRD

Opus Genetics
IRD

33 hedge funds and large institutions have $7.3M invested in Opus Genetics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

128% more capital invested

Capital invested by funds: $3.2M → $7.3M (+$4.1M)

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

6% more funds holding

Funds holding: 31 → 33 (+2)

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$793K
2
Renaissance Technologies
Renaissance Technologies
New York
+$233K
3
BlackRock
BlackRock
New York
+$121K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$101K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$45.2K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$1.04M
2
AFM
Anson Funds Management
Texas
-$768K
3
TSS
Two Sigma Securities
New York
-$15K
4
TRCT
Tower Research Capital (TRC)
New York
-$4K
5
UBS Group
UBS Group
Switzerland
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$2.94M +$233K +1,796 +18%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.66M +$793K +6,115 +128%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$658K +$101K +779 +41%
BlackRock
4
BlackRock
New York
$229K +$121K +933 New
Northern Trust
5
Northern Trust
Illinois
$155K +$22.9K +177 +39%
HVIA
6
Hudson Valley Investment Advisors
New York
$102K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$86K +$45.2K +349 New
NFC
8
Northeast Financial Consultants
Connecticut
$76K – – –
Bank of New York Mellon
9
Bank of New York Mellon
New York
$65K +$2.2K +17 +7%
BMC
10
Benin Management Corp
Connecticut
$63K +$2.72K +21 +9%
GC
11
Guggenheim Capital
Illinois
$42K +$3.76K +29 +20%
Citadel Advisors
12
Citadel Advisors
Florida
$40K +$21.1K +163 New
Millennium Management
13
Millennium Management
New York
$26K +$13.7K +106 New
Goldman Sachs
14
Goldman Sachs
New York
$21K – – –
State Street
15
State Street
Massachusetts
$21K – – –
NWM
16
Northwest Wealth Management
Iowa
$20K – – –
Wolverine Trading
17
Wolverine Trading
Illinois
$19K – – –
FHC
18
First Heartland Consultants
Missouri
$11K – – –
VKH
19
Virtu KCG Holdings
New York
$11K +$1.69K +13 +42%
Cambridge Investment Research Advisors
20
Cambridge Investment Research Advisors
Iowa
$9K +$2.2K +17 +81%
CCM
21
Compton Capital Management
Rhode Island
$8K +$4.02K +31 New
KWM
22
Kingsview Wealth Management
Oregon
$7K +$3.5K +27 New
Wells Fargo
23
Wells Fargo
California
$5K -$648 -5 -20%
NPT
24
Nixon Peabody Trust
Massachusetts
$5K – – –
CB
25
Commerce Bank
Missouri
$5K +$2.72K +21 New
1
2

IRD Hedge Fund Activity: Q1 2017 in Review

33 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2017, worth a combined $7.3M — up 128% from $3.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IRD positions and 6 closed out — a net gain of 5 holders — while 10 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $793K. The largest seller was Sabby Management, exiting entirely with an estimated $1.04M sold.

  • 33 institutional investors held Opus Genetics (IRD) as of Q1 2017, up from 31 in Q4 2016.
  • Funds reported $7.3M of Opus Genetics stock for Q1 2017, up 128% quarter-over-quarter.
  • 11 funds opened new Opus Genetics positions in Q1 2017 and 6 closed out, a net change of +5 holders.
  • The largest Opus Genetics buyer in Q1 2017 was Vanguard Group, an estimated $793K added.
  • The largest Opus Genetics seller in Q1 2017 was Sabby Management, an estimated $1.04M sold.

Based on aggregated 13F filings for Q1 2017.